# Early Beta Blocker Administration in STEMI Patients With SCAI B Status

> **NCT06967194** · NA · RECRUITING · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- ST Segment Elevation Myocardial Infarction (STEMI)
- Cardiogenic Shock Post Myocardial Infarction

## Interventions

- **DRUG:** Metoprolol (MET)
- **DRUG:** Plcacebo

## Key facts

- **NCT ID:** NCT06967194
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2027-05
- **Final completion:** 2027-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967194, "Early Beta Blocker Administration in STEMI Patients With SCAI B Status". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06967194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*